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Oxidative stress represents excessive intracellular levels of reactive oxygen species (ROS), which plays a
major role in the pathogenesis of cardiovascular disease. Besides having a critical impact on the devel-
opment and progression of vascular pathologies including atherosclerosis and diabetic vasculopathy,
oxidative stress also regulates physiological signaling processes. As a cell permeable ROS generated by
cellular metabolism involved in intracellular signaling, hydrogen peroxide (H2O2) exerts tremendous
impact on cardiovascular pathophysiology. Under pathological conditions, increased oxidase activities
and/or impaired antioxidant systems results in uncontrolled production of ROS. In a pro-oxidant en-
vironment, vascular smooth muscle cells (VSMC) undergo phenotypic changes which can lead to the
development of vascular dysfunction such as vascular inﬂammation and calciﬁcation. Investigations are
ongoing to elucidate the mechanisms for cardiovascular disorders induced by oxidative stress. This re-
view mainly focuses on the role of H2O2 in regulating physiological and pathological signals in VSMC.
& 2016 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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Oxidative signaling is critical for cell homeostasis and survival.
Reactive oxygen species (ROS) are the small molecules responsible
for this signaling, and they are produced at low levels continually
during normal cell function. In particular, hydrogen peroxide
(H2O2) has become recognized as a crucial mediator of cellular
oxidative signaling [1,2]. The physiological level of H2O2 is main-
tained in the cell by a series of enzymatic actions, including
NADPH oxidases (NOX) and superoxide dismutases (SOD), through
the dismutation of superoxide anion (O2) [3,4]. H2O2 is essential
in signaling pathways determining cell viability, and it participates
in the cell's ability to combat bacteria and other pathogens [5].
Under pathological conditions, such as hypertension, diabetes, and
hyperlipidemia – the major risk factors of atherosclerosis, how-
ever, elevation of vascular NOX increased H2O2 production, which
leads to monocyte/macrophage inﬁltration, lipid oxidation, foam
cell formation that signiﬁcantly contribute to vascular inﬂamma-
tion and lesion development [6–8].
Recent studies by our group and others have elucidated a
mechanistic link between H2O2-induced oxidative stress and vas-
cular cell homeostasis and differentiation [9,10]. We have shown
that H2O2 induces phenotypic changes of vascular smooth muscle
cells (VSMC) that lead to vascular pathologies such as calciﬁcation
[9]. This review aims to highlight the role of H2O2 as a physiolo-
gical and pathological redox signal in VSMC, as well as newly
discovered molecular signals promoting oxidative stress in cardi-
ovascular diseases.2. Regulation of H2O2 production in VSMC
ROS can be generated following cell stimulation and function as
intracellular signaling molecules [11,12], and oxidative species
have been shown to be critical for cell homeostasis and survival
[13]. Excessive ROS generated by cellular metabolism, however,
causes cellular damage and tissue dysfunction [14]. H2O2, a cell
permeable ROS that can diffuse across biological membranes and
has a relatively long half-life among other ROS [15], has been
shown to serve as an effective redox signaling mediator that reg-
ulates intracellular signaling [16,17]. H2O2 is produced in vascular
cells by multiple enzymatic systems [18]. While mitochondria are
responsible for the majority of H2O2 production within the cell
under physiological conditions, some non-mitochondrial sources
of H2O2 have also been described, including vascular NOX, xan-
thine oxidase and uncoupled eNOS [19,20]. Under normal condi-
tions, constitutive oxidase activities and endogenous scavenger
systems, including catalase and glutathione peroxidases, maintain
steady-state H2O2 levels in vascular tissue [20,21] H2O2 is im-
portant to maintain VSMC function under physiological conditions,
such as proliferation, migration, and differentiation [22,23]. Upon
stimulation, multiple oxidase systems in the endothelium, media,
and adventitia can produce H2O2 and contribute to elevation of
H2O2 in VSMC [24,25]. Exogenous H2O2 can further induce pro-
duction of endogenous H2O2 by activating cellular NOX [3]. In this
way, chronically accumulated H2O2 leads to VSMC dysfunction and
damage in the vasculature [26].
2.1. Mitochondrial H2O2 production
The precursor of H2O2, superoxide anion (O2), is produced
mainly by complexes I and III in the mitochondrial respiratory
chain [27,28]. Superoxide anion generated in the intermembrane
space can be carried across the membrane to the cytosol via anion
channels [29]. The presence of mitochondrial SOD-2, which con-
sumes superoxide anion as it is produced and converts it to H2O2,and other similar enzymes, protects the mitochondrion itself from
the damaging effects of ROS [30]. Several studies have described
the production of superoxide anion by the mitochondrial re-
spiratory complexes [31–33]. The contributions of each of the
complexes and individual enzymes to the overall superoxide anion
production vary depending on the organ and the reduced state of
the complexes. Also the capacity of each site relies on the abun-
dance of the enzymes or complex in the mitochondria. IQ in
Complex I has been determined to be the predominant center of
production for superoxide anion and/or H2O2 in the mitochondria
during reverse electron transport [34]. Among eleven sites of su-
peroxide anion and/or H2O2 production in mitochondria, most of
the sites release superoxide anion and H2O2 exclusively in the
mitochondrial matrix due to their location in the matrix or at the
inner face of the matrix. While site IIIQo in Complex III and GQ
linked to the mitochondrial glycerol 3-phosphate dehydrogenase
generate superoxide anion and/or H2O2 to the external side of the
mitochondrial inner membrane and the matrix. The topological
differences in the release of superoxide anion and H2O2 to differ-
ent compartments in the mitochondria are likely to have sig-
niﬁcant impact on downstream redox signaling [34]. To better
understand the role of mitochondrial ROS in oxidative damage and
redox signaling in the vasculature, state-of-the-art methods to
measure mitochondrial superoxide anion and H2O2 formation
in vivo are deﬁnitely needed as the generation within the mi-
tochondrial matrix highly depends on local oxygen concentration
and redox groups bound to relevant protein, which are all highly
variable and difﬁcult to measure in vivo.
Non-mitochondrial H2O2 Production.
Many non-mitochondrial enzymes have been shown to pro-
duce H2O2 [35,36]. Xanthine oxidase produces H2O2 as an inter-
mediate for the reaction in which xanthine is converted to uric
acid [37,38]. Lipoxygenase produces oxidized linoleic acid and
cyclooxygenase produces prostaglandins from arachidonic acid,
each of which results in H2O2 production [39]. These systems are
known to participate in the redox signaling under physiological
conditions, while causing toxic cellular effects and diseases once
their activity is dysfunctional.
On the other hand, NOX, a multi-enzyme complex, produces
H2O2 or superoxide anion primarily, not as a part of other reactions
[35,40]. NOX exists in many different isoforms, all using NADPH as
a donor of the electron to generate H2O2 or superoxide anion [41].
In VSMC, Nox1, Nox2, and Nox4 have been linked to multiple
cardiovascular diseases, including hypertension, atherosclerosis,
and diabetic vasculopathy [42–45]. Nox1 is primarily found in
caveolae, endosomes, and plasma membranes of VSMC [46] and it
has a critical role in VSMC proliferation in response to angiotensin
II (Ang II), PDGF, and thrombin [47–49]. Nox1-deﬁciency inhibited
injury-induced neointimal formation, which was associated with
inhibition of VSMC proliferation and migration [50]. In contrast,
enhanced activation of Nox1 by increased NoxA1, an activator of
Nox1, in the vasculature increased superoxide anion generation in
VSMC and increased neointimal hyperplasia and atherosclerosis
[49]. Similarly, increased Nox1 expression in cultured VSMC or
aortic segments induced VSMC proliferation [51]. Although the
precise molecular mechanisms underlying Nox1-mediated pro-
liferation of VSMC are not well deﬁned, activation of a small GTP-
binding protein ADP-ribosylation factor 6 and MAPK signaling
pathways are demonstrated in Ang II-induced VSMC proliferation
[47]. Nox2 is expressed in endosomal and phagosomal membranes
and is regulated in a similar way to vascular Nox1 [52]. Nox2 has
also been described as an important regulator of ﬁbroblast pro-
liferation since its downregulation results in reduction of serum-
induced proliferation [122,123]. Recent report demonstrates that
ROS-derived from Nox2, an important regulator of ﬁbroblast pro-
liferation act as a paracrine stimulus on neointimal hyperplasia
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has been shown to play an important role in focal adhesions and
maintenance of differentiated status of VSMC [54]. A recent study
suggests that Nox4 is critical for transforming growth factor beta-
regulated expression of VSMC differentiation marker, such as
smooth muscle α-actin, by activation of a p38 and serum-response
factor/myocardin-related transcription factor pathway NOX-gen-
erated H2O2 in VSMC has been shown to be extensively involved in
hypertrophy, proliferation, migration, and inﬂammation [55].
Therefore, the NOX enzymes have become recognized as highly
important targets in the development of therapeutic strategies for
ROS production in physiological and pathological conditions.
2.2. Physiological roles of H2O2 in VSMC
Although high levels of ROS cause cellular dysfunction and
damage in the vasculature, normal levels of ROS are important to
maintain physiological responses. In particular, H2O2 plays an
important role in cellular signaling in a range of biological pro-
cesses in many organisms. Due to its ability to travel through
membranes, H2O2 is involved in signaling in every cellular orga-
nelle. H2O2 has been well recognized as a critical mediator of
VSMC function under physiological conditions, such as prolifera-
tion, migration, and differentiation as well as modulation of vas-
cular tone.
As H2O2 activates some common signaling molecules and
pathways induced by growth factors, it has long been regarded as
an early growth signal. Brown et al. showed in an early study that
H2O2 promotes VSMC proliferation [56]. They found that over-
expression of catalase, the enzyme that hydrolyzes H2O2, reduces
H2O2 production in rat VSMC and inhibits cell growth, suggesting
that endogenously produced- H2O2 at physiological levels may
play a fundamental role in VSMC proliferation. On the other hand,
exogenous addition of H2O2 (10 nM to 100 mM) to growth-arrested
human VSMC was found to stimulate an increase in cell growth,
which was antagonized by catalase in a dose-dependent manner
[57]. Similarly, in growth-arrested rabbit VSMC, H2O2 synergisti-
cally enhanced angiotensin II-induced VSMC proliferation [58]. In
human coronary artery smooth muscle cells, H2O2 increased the
half-life and induced the expression of placenta growth factor [59],
an important mediator of arteriogenesis [60,61] that regulates
angiotensin II-induced VSMC proliferation [62]. Collectively, these
results support the notion that H2O2 is a critical regulator of VSMC
proliferation under physiological conditions.
Migration of VSMC is an important process in the development
of blood vessels as well as vascular pathology, including neointi-
mal formation and atherosclerosis. Platelet-derived growth factor
(PDGF) is one of the most potent migratory factors for VSMC.
PDGF-induced migration of VSMC was attenuated by pre-treat-
ment with antioxidants including N-acetyl-cysteine, the glu-
tathione peroxidase (GPx) mimetic, ebselen, as well as catalase,
the scavengers of H2O2, indicating an important role of H2O2 as a
cellular mediator in PDGF-induced VSMC migration [63]. In addi-
tion, insulin and insulin-like growth factor 1 signals have been
shown to play important roles in vascular remodeling. Similar to
exogenously added H2O2, H2O2-induced by insulin/insulin-like
growth factor 1 was found to elevate motility of rat VSMC, which
was blocked by catalase [64]. Recently, an elegant study by de
Rezende et al. showed that H2O2 oxidizes speciﬁc cysteine residues
within the α7 subunit of integrin α7β1, which facilitates VSMC
formation of membrane protrusions via binding to laminin-111,
thereby enhancing the binding afﬁnity of integrin to laminin that
increases VSMC migration [65].
In addition to its roles in regulating VSMC physiological re-
sponses such as proliferation and migration, H2O2 has also been
demonstrated to regulate differentiation of VSMC from theirprecursors as well as phenotypic changes between “contractile”
state and “synthetic” state. Xiao et al. found that a set of SMC-
speciﬁc genes was signiﬁcantly upregulated in mouse embryonic
stem cells cultured on collagen IV-coated plates, which was cor-
related with an increased expression of NOX4, the H2O2 producing
enzyme [66]. They further demonstrated that NOX4 induced-H2O2
mediated the differentiation of stem cells into VSMC via activation
of SMC-speciﬁc transcription factors, including serum response
factor and myocardin. In contrast, inhibition of NOX4 activity due
to the deﬁciency of polymerase delta interacting protein 2 reduced
H2O2 production in VSMC, which resulted in an elevated secretion
of collagen I in VSMC and led to increased stiffness, reduced
compliance, and excessive extracellular matrix deposition in mice,
implicating phenotypic changes of VSMC into synthetic forms
under reduced H2O2 level [67]. On the other hand, exogenous
addition of H2O2 was found to directly induce the expression of
microRNA-145 in rat VSMC, which increased the expression and
activity of the key VSMC transcriptional factor, myocardin [68].
Consistently, increased H2O2 production in VSMC from p22phox-
over-expressing mice exhibited increased expression of synthetic
phenotypic markers concomitantly with decreased contractile
markers, supporting the regulation of H2O2 production on VSMC
phenotypic modulation [69].
In the vascular walls, endothelial cells modulate underlying
VSMC and vascular tone by releasing relaxing and contracting
factors, including nitric oxide and H2O2 [70,71]. In human coronary
arterioles, shear stress induces endothelial cell-derived H2O2 that
results smooth muscle hyperpolarization and relaxation, which
could be abrogated by polyethylene glycol catalase [71]. In rat
renal artery, acetylcholine triggers transient smooth muscle con-
traction in an endothelium-dependent manner [72]. Inhibition of
NOX, however, attenuates acetylcholine-induced smooth muscle
contraction, suggesting that acetylcholine stimulates NOX-derived
H2O2 production in endothelial cells that leads to smooth muscle
contraction [72]. Therefore, endothelial production of H2O2 may
act as endothelium-derived hyperpolarization factor that regulates
VSMC function and vascular tone.
2.3. Scavengers of H2O2
Under normal conditions, the level of H2O2 is maintained in
steady-state in the vasculature by constitutive oxidase activities
and endogenous scavenger systems, including the major families
of antioxidant enzymes: SOD, catalase, glutathione peroxidases,
and thioredoxin peroxidases. These antioxidant enzymes play
important roles as molecular sensors and biological modulators of
the effects exerted by ROS on cellular signaling events.
There are three SOD isoforms in human: cytoplasmic SOD1 (Cu-
Zn), mitochondrial SOD2 (Mn), and extracellular SOD3 (Cu-Zn).
SOD1 knockout mice exhibit increased superoxide anion while
reduced cytoplasmic H2O2 in pulmonary arteries, resulting in an
increase in the ratio of superoxide anion H2O2 in pulmonary ar-
terial SMC that led to vascular inﬂammation and pulmonary hy-
pertension [73]. Accordingly, ﬁne-tuning the balance among ROS
by anti-oxidant enzymes such as SODs regulates cellular oxidative
signaling pathways in VSMC.
Catalase acts more directly to decompose H2O2 into water and
oxygen; its importance is reﬂected by its ubiquity in all oxygen-
consuming organisms. The expression and activity of catalase in
aortic wall were closely correlated with the formation of abdom-
inal aortic aneurysms (AAA) in mice. It was shown that the ad-
ministration of PEG-catalase prevents the loss of tunica media and
the formation of AAA induced by calcium chloride on mouse in-
frarenal aortas [74]. Similarly, over-expression of catalase in VSMC
results in enhanced VSMC survival and reduced AAA formation
through restored catalase activity and decreased matrix
Fig. 1. Regulation and function of hydrogen peroxide in modulating VSMC physiology and vascular dysfunction, such as vascular inﬂammation and calciﬁcation. Hydrogen
peroxide (H2O2) is produced in vascular smooth muscle cells (VSMC) through mitochondrial respiratory chain and non-mitochondrial enzymatic systems via superoxide
anion (O2), converted to H2O2 by superoxide dismutases (SOD). One of the major families of antioxidant enzymes, catalase directly catalyzes H2O2 into water. Glutathione
peroxidases (GPx) and peroxiredoxins (Prx) scavenge H2O2 by the use of reducing power of glutathione (GSH) and thioredoxin (Trx). Under physiological conditions,
homeostasis of cellular redox status is maintained by keeping the steady-state levels of H2O2 through the balance between oxidase systems and antioxidant machinery,
allowing H2O2 to serve as a critical modulator of cellular signaling events. Excessive accumulation of H2O2 by increased oxidase activities and/or impaired antioxidant
systems, however, leads to the pathological conditions, such as increased vascular inﬂammatory responses and VSMC calciﬁcation. GSH, reduced glutathione; GSSG, oxidized
glutathione; Trx (red), reduced thioredoxin; Trx (ox), oxidized thioredoxin. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
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human catalase in the atherogenic ApoE / mice contributes to
the retarded atherosclerotic development correlated with the re-
duced F2-isoprostanes in the plasma and aortas, suggesting that
H2O2 is implicated in the formation of oxidized lipids and the
development of atherosclerosis in ApoE/ mice [75].
More recently, studies with the use of new animal models have
demonstrated the importance of the glutathione peroxidase (GPx)
antioxidant systems in maintaining vascular redox balance. Eight
different isoforms of GPx have been currently identiﬁed in humans
and each functions as a reducing molecule of H2O2 to water. GPx1 is
the predominant glutathione peroxidase isoform in the vasculature.
VSMC from GPx1-haplodeﬁcient mice demonstrated increased oxi-
dative stress that led to NF-κB activation, VSMC proliferation, and an
inﬂammatory response [76]. Global knockout of GPx1 in ApoE /
mice resulted in increased oxidative stress and accelerated devel-
opment of atherosclerotic lesions [77], supporting a direct role of
GPx1 in regulating the development of vascular disease.In addition, the thioredoxin system in vascular cells has been
recognized as a critical anti-oxidizing entity and seems to mostly
depend on thioredoxin peroxidase (peroxiredoxin, Prx) for its ROS-
scavenging activities. Over-expression of Prx4 led to the attenua-
tion of atherosclerotic development in ApoE / mice through the
suppression of oxidative damage indicated by reduced markers of
oxidative stress (8-hydroxy-2'-deoxyguanosine and oxLDL) and
down-regulation of apoptosis [78]. Similarly, the deﬁciency in Prx2
results in increased production of H2O2 through enhanced acti-
vation of PDGF signaling and subsequent cell proliferation, while
the forced expression of Prx2 in VSMC attenuates PDGF-induced
activation of the PDGFR-β, possibly through inhibition of PDGF-
induced H2O2 production [79]. Accordingly, Prx 2/4 might affect
H2O2-induced mitogenic and migratory signaling, thus contribut-
ing to PDGF-induced VSMC proliferation and migration during
neointimal formation [78,79].
New ﬁndings at the subcellular level have furthered our un-
derstanding of redox balance in the vasculature. Cellular
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cient system of control for H2O2 at its site of generation. Activities
of GPx or thioredoxin systems have been observed in several
distinct subcellular locations, depending on the isoforms and the
cellular environment. In mammals, GPx1 is found in the cytoplasm
while GPx2 and GPx3 are mainly expressed extracellularly [80].
Mammalian cells also express two thioredoxin systems: the cy-
tosolic thioredoxin 1 and the mitochondrial thioredoxin 2 [81].
Therefore, ROS, including H2O2, may be appropriately monitored
and regulated by distinctly located antioxidant systems both in-
tracellularly and extracellularly. Such a notion is supported by
recent studies with targeted expression of the antioxidant en-
zymes in speciﬁc subcellular compartments. For instance, ex-
pression of Prx 5 in the mitochondrial intermembrane space was
found to inhibit hypoxia-induced oxidative signaling in the mi-
tochondrial intermembrane space as well as the cytosol in pul-
monary arterial SMC [82]. Additionally, expression of a mi-
tochondria-exclusive variant form of GPx1 resulted in a higher
level of oxidative stress compared to cells expressing GPx1 mostly
in the cytoplasm where the natural counterpart of GPx1 [83],
further demonstrating the importance of the subcellular localiza-
tion of the antioxidant enzymes.
2.4. H2O2-regulated signaling pathways
Hydrogen peroxide is a relatively weak oxidizing agent; how-
ever, it could reversibly and covalently induce post-translational
modiﬁcations of cysteine thiolate residues resulting in changes in
activity and function of target proteins [84]. H2O2 sensors exist
throughout the cell to maintain cellular homeostasis. A variety of
protein kinases, which bear a redox-sensitive cysteine residues in
the kinases themselves or in their upstream signaling molecules,
are involved in the alteration of VSMC function by catalyzing the
phosphorylation of their target proteins. H2O2 has been implicated
in the activation of c-Src, protein kinase C (PKC), phosphatidyl
inositol (PI)3-kinase, protein kinase B (AKT), extracellular-regu-
lated kinase (ERK), c-Jun N-terminal kinases (JNK), and mitogen-
activated protein kinases (MAPK) [9,85–88]. H2O2 can induce
downstream signaling by both autocrine and paracrine mechan-
isms. Recent studies show that H2O2 may be transported through
membrane pores or by matrix vesicles [15,89], but this movement
has yet to be well characterized.
The redox-sensitive protein kinases, MAPKs, are key regulators of
signaling pathways that govern diverse cellular responses such as
proliferation, differentiation, growth, and inﬂammatory responses
[90]. Although MAPK are not known to be directly redox signaling
sensitive, they experience redox regulation by ROS-activated up-
stream molecules such as src-family kinases and PKC [91,92]. En-
hanced phosphorylation of ERK and p38 MAPK by H2O2 is observed
in VSMC and endothelial cells, reportedly through the activation of
an upstream src-family kinases and PKC, which results in the altered
vascular function such as VSMC constriction [93,94]. ROS-dependent
phosphorylation on Thr423 of p21-activated protein kinase has also
been shown to regulate VSMC migration induced by PDGF [63].
Emerging evidence has connected ROS to PI3K signaling. PI3K sig-
naling is activated in response to the exogenous H2O2 in various cell
types [95]. H2O2 induces NADPH oxidase-mediated ROS which is
dependent on PI3K/AKT signaling [96]. Thus, ROS activate PI3K,
which in turn promotes the process leading to ROS accumulation.
H2O2 has been shown to induce tyrosine phosphorylation of p110
(PI3K subunit) and enhances PI3K membrane recruitment to its
substrate site, thereby enabling PI3K to maximize its catalytic efﬁ-
ciency [97]. H2O2-activated PI3K can lead to activation of AKT [98].
AKT acts as a transducer of PI3K signaling initiated by many stimuli
and activates multiple cellular signaling pathways that regulates
proliferation, differentiation, and survival [9,99,100].On the other hand, protein tyrosine phosphatases (PTP) are
directly inhibited by ROS via thiol modiﬁcations of cysteine re-
sidues in their catalytic sites [101]. The tumor suppressor phos-
phatase and tensin homolog (PTEN), which antagonizes the sig-
naling cascade regulated by PI3K/AKT, is oxidatively inactivated by
mitochondrial NOX-produced H2O2 [95]. In SOD2-overexpressing
endothelial cells, increased mitochondrial H2O2 increases the ratio
of inactive/active PTEN, which results in enhanced PI3K/AKT sig-
naling that induces the expression of the key regulator of angio-
genesis, vascular endothelial growth factor (VEGF) [102]. Further
studies are warranted to better understand the complex system of
H2O2-mediated regulation of kinases and phosphatases in VSMC.
Downstream of a number of the signaling cascades, ROS-sen-
sitive transcription factors determine gene expression in response
to changes in redox balance. NF-κB is a critical transcription factor
for the proliferation, survival, and inﬂammatory responses in
VSMC. Enhanced H2O2 in GPx1-deﬁcient VSMC induces activation
of NF-κB in quiescent VSMC, and thus leading to VSMC prolifera-
tion [76]. The nuclear factor erythroid 2-related factor 2 (Nrf2), a
redox sensitive transcription factor, has also been shown to in-
crease the expression of antioxidant enzymes that protect VSMC
against oxidative stress [105,106]. Under low oxidative stress, Nrf2
is sequestered by Kelch-like ECH Associated Protein 1 and targeted
for proteasomal degradation [107]. In high oxidative stress con-
ditions, such as atherosclerotic and diabetes, activation of Nrf2-
regulated antioxidant systems has been demonstrated in vascular
endothelial cells and VSMC [108]. In addition, Furthermore, H2O2
has also been shown to induce phosphorylation of the cyclic AMP
response element–binding protein (CREB), a transcription factor
that is known to play an important role in neuron cell survival
[103]. In contrast, hypoxia increases intracellular H2O2 via in-
creased expression of NOX in pulmonary arterial smooth muscle
cells (PASMC), thus inhibiting CREB and increasing PASMC pro-
liferation [104]. The cell type-dependent differential regulation of
CREB by H2O2 indicates the ﬁne-tuning of cellular H2O2 signaling.
2.5. Pathological effects of hydrogen peroxide on vascular smooth
muscle cells
Excessive generation of ROS induced-oxidative stress is a pre-
dominant factor that accelerates the progression of cardiovascular
diseases, including atherosclerosis and vascular calciﬁcation [109–
111]. Multiple risk factors associated with pathogenesis of ather-
osclerosis including hypercholesterolemia, diabetes, hypertension,
smoking, and family history of heart attacks are all unequivocally
linked to increased oxidative stress in the vasculature [112]. Pa-
thological impact exerted by H2O2 on VSMC most relevant to the
onset and aggravation of the disease will be further discussed.
2.6. H2O2 induces VSMC inﬂammation
Atherosclerosis has been well characterized as a prolonged
inﬂammatory state within the cardiovascular system, in which a
variety of cell types, including VSMC, endothelial cells, macro-
phages, and immune cells interact with each other and elicit po-
tent inﬂammatory reactions in response to a variety of cellular
stimuli. Recruitment and inﬁltration of blood-borne monocytes/
macrophages into the arterial wall plays an important role in the
development of atherosclerosis [113,114]. The inﬁltrated in-
ﬂammatory cells produce tumor necrosis factor-alpha (TNF-α), a
major pro-inﬂammatory cytokine in the development of athero-
sclerosis, which promotes the generation of ROS such as H2O2 via
NOX- or mitochondria-dependent pathways [115–117]. Local H2O2
production from both vascular cells and inﬁltrated cells initiates a
signaling cascade which leads to the inﬂammatory response
through the expression of inﬂammatory cytokines and adhesion
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VSMC during the development of atherosclerosis has also been
well documented. In response to TNF-α, NF-κB signaling is acti-
vated in VSMC, which leads to increased expression of pro-in-
ﬂammatory molecules such as vascular cell adhesion molecule-1,
monocyte chemoattractant protein-1 (MCP-1), and fractalkine
[120]. In rat VSMC, H2O2 treatment induces an increase in in-
tracellular and extracellular osteopontin, an important mediator of
inﬂammation and generation of atherosclerotic lesions [121]. In
contrast, transgenic mice overexpressing VSMC-speciﬁc catalase,
the enzyme that hydrolyzes H2O2, exhibit signiﬁcant reduction in
inﬂammatory molecules in the vessel walls, including TNF-α along
with other inﬂammatory markers such as TGF-β, osteopontin, IL-
1β, and MCP-1 [74]. These observations support a critical role of
H2O2 produced by VSMC in regulating vascular inﬂammation.
Furthermore, lowered macrophage inﬁltration into the arterial
wall is observed in these catalase-overexpressing mice [74].
Therefore, VSMC-produced H2O2 may contribute to the overall
progression of atherosclerosis by regulating the expression of in-
ﬂammatory molecules in the vascular cells as well as the inﬁltra-
tion of inﬂammatory cells. In addition, studies from our group
have demonstrated that H2O2 induces the expression of the re-
ceptor activator of nuclear factor kappa-B ligand (RANKL) in VSMC,
which promotes macrophage inﬁltration [122,123]. The expression
of RANKL is low in normal arteries, but increased in athero-
sclerosis and vascular calciﬁcation [124]. Our ﬁnding has sup-
ported a novel role of H2O2-stimulated RANKL elevation by VSMC
in promoting macrophage inﬁltration in the pathogenesis of
atherosclerosis. As indicated above, the inﬁltrated monocytes/
macrophages induce production of inﬂammatory molecules as
well as H2O2 from the activated inﬂammatory cells, forming a vi-
cious cycle of H2O2 and inﬂammatory cytokine production in the
vasculature.
2.7. H2O2 induces VSMC calciﬁcation
One of the characteristic features of atherosclerosis is the de-
velopment of vascular calciﬁcation, which reduces the elasticity
and decreases the compliance of vessel walls [125]. Although the
presence of vascular calciﬁcation has long been recognized, we
have only begun to understand the underlying mechanisms that
regulate the development of vascular calciﬁcation in the last two
decades. It is now well accepted that vascular calciﬁcation is not
simply a passive precipitation of hydroxyapatite crystals but a
regulated process that vascular cells differentiate into bone-like
cells, a process resembling embryonic osteogenesis [126,127].
We and others have shown that oxidative stress is a major
cause of vascular calciﬁcation [9,128–130]. Increased oxidative
stress has been well documented in human atherosclerotic lesions.
Studies by Terentis et al. have demonstrated oxidation of toco-
pherol along with LDL oxidation early in lesion formation [131].
Several studies have proven that oxidative stress signaling is pa-
thologically increased in many cell types involved in athero-
sclerosis, including platelets [132], endothelial cells [133], macro-
phages [134], and VSMC [129]. We have reported that increased
oxidative stress is associated with vascular calciﬁcation in
atherogenic ApoE / mice [122,123]. Increased oxidative stress
induces the expression of Runx2, a protein normally expressed in
osteoblasts [135]. The critical role of Runx2 in vascular calciﬁcation
is highlighted using mice with smooth muscle cell-speciﬁc genetic
deletion of Runx2, which exhibit decreased vascular calciﬁcation
and even show attenuation in overall atherosclerosis [122]. In vitro
studies with human VSMC further show that many of the com-
ponents causing atherosclerosis such as cholesterol and hy-
perglycemia, increase oxidative stress and associated signaling
[136,137]. Sustained elevation in oxidative stress ultimately resultsin atherosclerosis. The observation that oxidant generation is
predominant near the calcifying foci [129] suggests the regulation
of vascular calciﬁcation by redox signaling. Increased ROS, parti-
cularly H2O2, found around calcifying foci, may be attributed to
enhanced expression of the oxidases, including Nox2, p22phox,
and Nox4 [129], or may be due to reduced antioxidant systems
such as catalase and SOD in calciﬁed aortic valve [130].
Increased oxidative stress is also manifested in diabetic sub-
jects [138] and in the vasculature of diabetic animals [139], where
vascular calciﬁcation is predominantly identiﬁed in the media of
VSMC. Speciﬁc mechanisms may be responsible for the oxidative
stress observed in diabetes, independent of atherosclerosis or
other cardiovascular diseases. Recent studies have shown that
advanced glycation end products (AGEs) cause VSMC calciﬁcation
in vitro through increased oxidative stress [139,140]. Diabetic pa-
tients and murine models exhibit increased expression of AGEs,
which bind to the receptor for advanced glycation to increase
oxidative stress [141,142]. This is a non-enzymatic mechanism of
oxidative stress generation, caused by an excessive glucose which
is characteristic of diabetes [143]. The levels of AGEs are elevated
in diabetic patients as well, and are correlated with increased
vascular calciﬁcation in these patients [144]. According to previous
in vitro studies, the oxidative stress produced by the AGEs may be
the causative factor in diabetic vascular calciﬁcation in diabetic
patients [139,140,142].
In vitro studies have also shown that AGEs, which accumulate
in diabetic patients, induce VSMC calciﬁcation, via increased oxi-
dative stress by Nox4 and p22phox-dependent signals [140]. Our
recent studies have highlighted the novel function of protein
O-linked β-N-acetylglucosamine modiﬁcation (O-GlcNAcylation)
in regulating vascular calciﬁcation in diabetes [145]. O-GlcNAcy-
lation plays crucial roles in the pathogenesis of human diseases,
especially chronic diseases, including diabetes and cardiovascular
diseases [146,147]. Elevation of O-GlcNAcylation is found in hu-
man diabetic carotid plaques [148] and diabetic mouse vasculature
[149]. Coincidently, increased calciﬁed plaques have been identi-
ﬁed in diabetic patients [150] and diabetic mouse models [151].
Elevated glucose and insulin resistance, two hallmarks of diabetes,
have been associated with increased intracellular stress and
O-GlcNAcylation [152]. Using low dose-streptozotocin-induced
mouse model of diabetes, we have demonstrated a novel causative
link between chronic increases in vascular O-GlcNAcylation and
vascular calciﬁcation in diabetes mellitus [145]. This ﬁnding adds
to our current growing knowledge on how oxidative stress may
regulate vascular calciﬁcation in different disease models.
Recent studies by our group and others have elucidated some
of the mechanisms linking oxidative stress and vascular calciﬁca-
tion. Demer and colleagues have shown that xanthine/xanthine
oxidase induces osteogenic differentiation of bovine calcifying
vascular cells via H2O2-activated signals [128]. Using primary
mouse VSMC, we have demonstrated that H2O2 directly induces
VSMC calciﬁcation, which is associated with the inhibition of
VSMC-speciﬁc markers and the upregulation of bone-speciﬁc
markers, indicating a phenotypic change of VSMC phenotype to an
osteogenic phenotype [9]. Of note, oxidative stress modulates os-
teogenic differentiation of vascular cells and bone cells in an op-
posite manner [128,153], increasing VSMC calciﬁcation but in-
hibiting osteoblast differentiation. In VSMC, increased oxidative
stress converted LDL into OxLDL, which promoted VSMC calciﬁ-
cation [154]. In contrast, minimally oxidized low-density lipopro-
tein (mmLDL) and H2O2 increased intracellular oxidative stress
and inhibited osteogenic differentiation of pre-osteoblasts or bone
marrow stromal cells [128]. Consistently, we demonstrated that
oxidative stress induced VSMC calciﬁcation by up-regulation of
Runx2, which is mediated by the activation of the AKT/FOXO1/3
signaling axis via inhibiting Runx2 ubiquitination that leads to
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oxidative stress in VSMC activates AKT by phosphorylation, nor-
mally a survival signal. The inhibition of AKT activation blocks
Runx2 expression and osteogenic differentiation of VSMC [9].
These observations support the notion that activation of oxidative
stress signaling while beneﬁcial for VSMC within a short time
frame, can be detrimental when chronically activated.
We have further demonstrated that oxidative stress-induced
Runx2 promotes the expression of RANKL in calcifying VSMC, via
direct binding to the RANKL promoter that enhances RANKL
transcription [123]. The RANKL/RANK system is critical for the
formation of osteoclasts, the bone-resorbing cells. Enriched OxLDL
in atherosclerotic plaques was found to increase oxidative stress in
VSMC and lead to increased RANKL in the atherosclerotic area
[156]. Consistently, we have shown that Runx2 upregulates
RANKL, which can attract osteoclast-like cells into the calciﬁed
area [123]. In atherosclerosis-prone ApoE/ mice, increases in
ROS were associated with up-regulation of Runx2 and RANKL in
the calciﬁed atherosclerotic lesions, accompanying the presence of
tartrate-resistant acid phosphatase (TRAP)-positive osteoclast-like
cells in this area [122,123]. On the contrary, smooth muscle-spe-
ciﬁc Runx2 deﬁciency down-regulated the expression of RANKL
and was accompanied by decreased macrophage inﬁltration and
reduced formation of osteoclast-like cells in the calciﬁed lesions
[122]. TRAP-positive cells have been previously observed in
atherosclerotic lesions [157,158], however, their origin and func-
tions are unknown. Our studies provided the evidence that VSMC-
derived RANKL promoted macrophage migration and differentia-
tion into osteoclasts [122,123], suggesting potential roles of
RANKL-induced macrophage-derived osteoclasts in the athero-
sclerotic lesions [159]. Accordingly, oxidative stress plays a critical
role in regulating VSMC function as well as VSMC crosstalk with
macrophages and others within the cellular milieu that promote
pathogenesis of vascular diseases.3. Conclusion remarks
As a signaling second messenger as well as a durable and ro-
bust oxidizing agent, hydrogen peroxide exerts a wide array of
effects on the physiology and pathology of the cardiovascular
system, particularly in VSMC (Fig. 1). Nonetheless, therapeutic
strategies are not established for the use of antioxidant regimen in
clinical practice. As ROS, especially H2O2, at low physiological
concentrations play an important role in intracellular signaling
pathways for maintaining homeostasis of vascular cells, the use of
antioxidants may not be as effective as expected. Future studies to
comprehensively understand vascular redox biology, especially
different spatiotemporal regulation of H2O2 production in VSMC
under physiological and pathological conditions, should elucidate
precise mechanisms by which this small redox molecule regulates
VSMC inﬂammatory responses in the pathogenesis of cardiovas-
cular diseases. In addition, unveiling H2O2–regulated signaling
molecule proﬁles in VSMC and other vascular cells may provide
novel molecular insights into the signaling cascades that mediate
the pathogenic effects of H2O2, and thus leading to identiﬁcation of
molecular targets. Further investigation of the regulatory roles of
VSMC in response to ROS including hydrogen peroxide involved in
the interplay among other cell types are clearly required as well to
develop therapeutic intervention targeted to cardiovascular
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